Panorama

Physicians Share Their Thoughts on DTP vs. DTC Advertising

Pharmaceutical companies are one of the largest advertisers in the overall marketplace and across ...

Will UnitedHealthcare’s New Rebate Strategy Put Pharma at Risk?

Earlier this month, UnitedHealthcare, a UnitedHealth Group company, announced it will expand pharmacy discounts ...

Pharma Made its Presence Known at SXSW 2018

At SXSW, while health doesn’t take center stage, it’s certainly a part of the ...

Who Needs to Care about Value Frameworks?

Public scrutiny on healthcare costs, particularly drug costs, has been mounting over the past ...

What Patients Really Want from AI in Healthcare

Lately, when people ask me about artificial intelligence and healthcare, I tend to talk ...

Taking a Super Bowl Approach to Medical Conferences

A funny thing happens when you talk “convention media.” People focus on how it ...

The Trouble with Sampling in the State of Ohio

Have you ever heard about Ohio’s Terminal Distributor of Dangerous Drugs (TDDD) licenses? Before ...

Next-Generation Forecasting Must Account for Payer Controls

The market access landscape for pharmaceutical products has shifted as payers struggle to control ...

How Drug Re-innovation Can Potentially Boost Pharma’s Depleting R&D Pipeline

The pharmaceutical industry’s typical R&D model of developing new chemical entities (NCEs) and creating ...